ArticleFrontiers in immunology2021

Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder.

Chen Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.